Wordt geladen...
Hairy cell leukemia – immunotargets and therapies
Hairy cell leukemia (HCL) is an indolent low-grade B-cell lymphoproliferative disorder that is reasonably sensitive to standard first-line purine analog therapy. However, in many cases, repeat relapses occur, requiring multiple courses of purine analog therapy, promoting eventual drug resistance. Th...
Bewaard in:
| Gepubliceerd in: | Immunotargets Ther |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918239/ https://ncbi.nlm.nih.gov/pubmed/27471703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S31425 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|